当前位置: X-MOL 学术Oxidative Med. Cell. Longev. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Hypoxia-Inducible Factor-1: A Potential Target to Treat Acute Lung Injury
Oxidative Medicine and Cellular Longevity Pub Date : 2020-11-17 , DOI: 10.1155/2020/8871476
Yang Liu 1 , Du Xiang 1 , Hengcheng Zhang 2 , Hanlin Yao 1 , Yanfeng Wang 1
Affiliation  

Acute lung injury (ALI) is an acute hypoxic respiratory insufficiency caused by various intra- and extrapulmonary injury factors. Presently, excessive inflammation in the lung and the apoptosis of alveolar epithelial cells are considered to be the key factors in the pathogenesis of ALI. Hypoxia-inducible factor-1 (HIF-1) is an oxygen-dependent conversion activator that is closely related to the activity of reactive oxygen species (ROS). HIF-1 has been shown to play an important role in ALI and can be used as a potential therapeutic target for ALI. This manuscript will introduce the progress of HIF-1 in ALI and explore the feasibility of applying inhibitors of HIF-1 to ALI, which brings hope for the treatment of ALI.

中文翻译:

低氧诱导因子-1:治疗急性肺损伤的潜在目标。

急性肺损伤(ALI)是由多种肺内和肺外损伤因素引起的急性低氧性呼吸功能不全。目前,肺部过度炎症和肺泡上皮细胞的凋亡被认为是ALI发病机理的关键因素。缺氧诱导因子1(HIF-1)是一种氧依赖性转化活化剂,与活性氧(ROS)的活性密切相关。已经显示出HIF-1在ALI中起重要作用,并且可以用作ALI的潜在治疗靶标。该手稿将介绍HIF-1在ALI中的研究进展,并探讨将HIF-1抑制剂应用于ALI的可行性,这为ALI的治疗带来了希望。
更新日期:2020-11-17
down
wechat
bug